Literature DB >> 17600694

Comparative ultrastructural analyses of platelets and fibrin networks using the murine model of asthma.

E Pretorius1, O E Ekpo, E Smit.   

Abstract

The murine Balb/c asthma model has been used successfully for a number of in vivo immunological applications and for testing novel therapeutics, and it is a reliable, clinically relevant facsimile of the human disease. Here we investigate whether this model can be used to study other components of the human body, e.g. ultrastructure. In particular, we investigate the effect of the phytomedicine Euphorbia hirta (used to treat asthma), on the ultrastructure of fibrin as well as platelets, cellular structures that both play an important role in the coagulation process. Hydrocortisone is used as positive control. Ultrastructure of the fibrin networks and platelets of control mice were compared to mice that were asthmatic, treated with two concentrations of hydrocortisone and one concentration of the plant material. Results indicate control mice possess major, thick fibers and minor thin fibers as well as tight round platelet aggregates with typical pseudopodia formation. Minor fibers of asthmatic mice have a netlike appearance covering the major fibers, while the platelets seem to form loosely connected, granular aggregates. Both concentrations of hydrocortisone make the fibrin more fragile and that platelet morphology changes form a tight platelet aggregate to a more granular aggregate not closely fused to each other. We conclude that E. hirta does not impact on the fragility of the fibrin and that it prevents the minor fibers to form the dense netlike layer over the major fibers, as is seen in untreated asthmatic mice. This ultrastructural morphology might give us better insight into asthma and the possible new treatment regimes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17600694     DOI: 10.1016/j.etp.2007.02.011

Source DB:  PubMed          Journal:  Exp Toxicol Pathol        ISSN: 0940-2993


  3 in total

1.  Eryptosis as a marker of Parkinson's disease.

Authors:  Etheresia Pretorius; Albe C Swanepoel; Antoinette V Buys; Natasha Vermeulen; Wiebren Duim; Douglas B Kell
Journal:  Aging (Albany NY)       Date:  2014-10       Impact factor: 5.682

2.  New design to remove leukocytes from platelet-rich plasma (PRP) based on cell dimension rather than density.

Authors:  Subhaini Jakfar; Tzu-Chieh Lin; Shinn-Chih Wu; Yao-Horng Wang; Yu-Jun Sun; Minal Thacker; Li-Xin Liu; Feng-Huei Lin
Journal:  Bioact Mater       Date:  2021-03-22

3.  An in vitro and in vivo study on the properties of hollow polycaprolactone cell-delivery particles.

Authors:  Barend Andre Stander; Fiona A van Vollenstee; Karlien Kallmeyer; Marnie Potgieter; Annie Joubert; Andri Swanepoel; Lara Kotze; Sean Moolman; Michael S Pepper
Journal:  PLoS One       Date:  2018-07-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.